| Long name: |
FITC-linked Antibody to Apolipoprotein E (APOE) |
| Antigen: |
Apolipoprotein E (APOE) |
| Other names: |
Apolipoprotein E, N/A, apo-E, apolipoprotein E, apolipoprotein E, apolipoprotein E3, apolipoprotein E |
| Gene name: |
APOE, Apolipoprotein E (APOE) |
| Gene synonims: |
AD2, APOE, Apo-E, LDLCQ5, LPG, APOE |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Due to limitted amount of tested species we cannot guarantee that no crossreactivity will occur |
| Specificity: |
, APOE, It has been selected for its ability to recognize APOE in immunohistochemical staining andwestern blotting, The antibody is a rabbit polyclonal antibody raised against APOE conjugated to fitc, This is an antibody designed to detect Apolipoprotein E (APOE) |
| Purification method: |
This antibody was purified via Affinity Chromatography |
| Form/Appearance: |
containing 0, pH7, 02% NaN3, 4, 50% glycerol, Supplied as solution form in PBS |
| Concentration: |
2mg/ml |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
Immunocytochemistry (ICC), Immunofluorescence (IF), Western Blot (WB), Immunohistochemistry (IHC) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
Apolipoprotein E (APOE) |
| Short name: |
Anti- Apolipoprotein E (APOE) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to Apolipoprotein E (apolipoprotein E) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
AD2 and LDLCQ5 and LPG, APOE and IDBG-56807 and ENSG00000130203 and 348, APOE and IDBG-639311 and ENSBTAG00000010123 and 281004, Apoe and IDBG-152108 and ENSMUSG00000002985 and 11816, cholinergic and biological process this GO :0007568 and aging and biological process this GO :0007603 and phototransduction, lipoprotein particle binding, nuclei, this GO :0000302 and response to reactive oxygen species and biological process this GO :0001523 and retinoid metabolic process and biological process this GO :0001540 and beta-amyloid binding and molecular function this GO :0001937 and negative regulation of endothelial cell proliferation and biological process this GO :0002021 and response to dietary excess and biological process this GO :0005102 and receptor binding and molecular function this GO :0005319 and lipid transporter activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005634 and nucleus and cellular component this GO :0005635 and nuclear envelope and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005764 and lysosome and cellular component this GO :0005768 and endosome and cellular component this GO :0005769 and early endosome and cellular component this GO :0005770 and late endosome and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005874 and microtubule and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006629 and lipid metabolic process and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0006707 and cholesterol catabolic process and biological process this GO :0006869 and lipid transport and biological process this GO :0006874 and cellular calcium ion homeostasis and biological process this GO :0006898 and receptor-mediated endocytosis and biological process this GO :0006979 and response to oxidative stress and biological process this GO :0007010 and cytoskeleton organization and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007263 and nitric oxide mediated signal transduction and biological process this GO :0007271 and synaptic transmission, this GO :0001540 : beta-amyloid binding, this GO :0001540 : beta-amyloid binding and also this GO :0005102 : receptor binding and also this GO :0005319 : lipid transporter activity and also this GO :0005515 : protein binding and also this GO :0005543 : phospholipid binding and also this GO :0008201 : heparin binding and also this GO :0008289 : lipid binding and also this GO :0016209 : antioxidant activity and also this GO :0017127 : cholesterol transporter activity and also this GO :0042802 : identical protein binding and also this GO :0042803 : protein homodimerization activity and also this GO :0046848 : hydroxyapatite binding and also this GO :0046911 : metal chelating activity and also this GO :0048156 : tau protein binding and also this GO :0050750 : low-density lipoprotein particle receptor binding and also this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity and also this GO :0070326 : very-low-density lipoprotein particle receptor binding and also this GO :0071813 : lipoprotein particle binding, this GO :0005102 : receptor binding, this GO :0005319 : lipid transporter activity, this GO :0005515 : protein binding, this GO :0005543 : phospholipid binding, this GO :0008201 : heparin binding, this GO :0008289 : lipid binding, this GO :0016209 : antioxidant activity, this GO :0017127 : cholesterol transporter activity, this GO :0042802 : identical protein binding, this GO :0042803 : protein homodimerization activity, this GO :0046848 : hydroxyapatite binding, this GO :0046911 : metal chelating activity, this GO :0048156 : tau protein binding, this GO :0050750 : low-density lipoprotein particle receptor binding, this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0070326 : very-low-density lipoprotein particle receptor binding, this GO :0071813 : lipoprotein particle binding, visible light and biological process this GO :0008201 and heparin binding and molecular function this GO :0008203 and cholesterol metabolic process and biological process this GO :0008219 and cell death and biological process this GO :0008289 and lipid binding and molecular function this GO :0009986 and cell surface and cellular component this GO :0010468 and regulation of gene expression and biological process this GO :0010544 and negative regulation of platelet activation and biological process this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010875 and positive regulation of cholesterol efflux and biological process this GO :0014012 and peripheral nervous system axon regeneration and biological process this GO :0015909 and long-chain fatty acid transport and biological process this GO :0016020 and membrane and cellular component this GO :0016209 and antioxidant activity and molecular function this GO :0017038 and protein import and biological process this GO :0017127 and cholesterol transporter activity and molecular function this GO :0019934 and cGMP-mediated signaling and biological process this GO :0030195 and negative regulation of blood coagulation and biological process this GO :0030425 and dendrite and cellular component this GO :0030516 and regulation of axon extension and biological process this GO :0030828 and positive regulation of cGMP biosynthetic process and biological process this GO :0031232 and extrinsic component of external side of plasma membrane and cellular component this GO :0032489 and regulation of Cdc42 protein signal transduction and biological process this GO :0032526 and response to retinoic acid and biological process this GO :0032805 and positive regulation of low-density lipoprotein particle receptor catabolic process and biological process this GO :0032868 and response to insulin and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034362 and low-density lipoprotein particle and cellular component this GO :0034363 and intermediate-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034365 and discoidal high-density lipoprotein particle and cellular component this GO :0034372 and very-low-density lipoprotein particle remodeling and biological process this GO :0034374 and low-density lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034380 and high-density lipoprotein particle assembly and biological process this GO :0034382 and chylomicron remnant clearance and biological process this GO :0034384 and high-density lipoprotein particle clearance and biological process this GO :0034447 and very-low-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042158 and lipoprotein biosynthetic process and biological process this GO :0042159 and lipoprotein catabolic process and biological process this GO :0042311 and vasodilation and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042802 and identical protein binding and molecular function this GO :0042803 and protein homodimerization activity and molecular function this GO :0043025 and neuronal cell body and cellular component this GO :0043407 and negative regulation of MAP kinase activity and biological process this GO :0043524 and negative regulation of neuron apoptotic process and biological process this GO :0043537 and negative regulation of blood vessel endothelial cell migration and biological process this GO :0043691 and reverse cholesterol transport and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045471 and response to ethanol and biological process this GO :0045541 and negative regulation of cholesterol biosynthetic process and biological process this GO :0045773 and positive regulation of axon extension and biological process this GO :0046848 and hydroxyapatite binding and molecular function this GO :0046889 and positive regulation of lipid biosynthetic process and biological process this GO :0046907 and intracellular transport and biological process this GO :0046911 and metal chelating activity and molecular function this GO :0048156 and tau protein binding and molecular function this GO :0048168 and regulation of neuronal synaptic plasticity and biological process this GO :0048709 and oli this GO dendrocyte differentiation and biological process this GO :0048844 and artery morphogenesis and biological process this GO :0050728 and negative regulation of inflammatory response and biological process this GO :0050750 and low-density lipoprotein particle receptor binding and molecular function this GO :0051000 and positive regulation of nitric-oxide synthase activity and biological process this GO :0051044 and positive regulation of membrane protein ectodomain proteolysis and biological process this GO :0051055 and negative regulation of lipid biosynthetic process and biological process this GO :0051651 and maintenance of location in cell and biological process this GO :0055088 and lipid homeostasis and biological process this GO :0055089 and fatty acid homeostasis and biological process this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0060999 and positive regulation of dendritic spine development and biological process this GO :0061000 and negative regulation of dendritic spine development and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070326 and very-low-density lipoprotein particle receptor binding and molecular function this GO :0071347 and cellular response to interleukin-1 and biological process this GO :0071363 and cellular response to growth factor stimulus and biological process this GO :0071397 and cellular response to cholesterol and biological process this GO :0071682 and endocytic vesicle lumen and cellular component this GO :0071813 and lipoprotein particle binding and molecular function this GO :0072358 and cardiovascular system development and biological process this GO :0072562 and blood microparticle and cellular component this GO :0090370 and negative regulation of cholesterol efflux and biological process this GO :0097113 and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering and biological process this GO :0097114 and N-methyl-D-aspartate receptor clustering and biological process this GO :1900221 and regulation of beta-amyloid clearance and biological process this GO :1901214 and regulation of neuron death and biological process this GO :1901215 and negative regulation of neuron death and biological process this GO :1901216 and positive regulation of neuron death and biological process this GO :1901627 and negative regulation of postsynaptic membrane organization and biological process this GO :1901628 and positive regulation of postsynaptic membrane organization and biological process this GO :1901630 and negative regulation of presynaptic membrane organization and biological process this GO :1901631 and positive regulation of presynaptic membrane organization and biological process this GO :1902004 and positive regulation of beta-amyloid formation and biological process this GO :1902430 and negative regulation of beta-amyloid formation and biological process this GO :1902947 and regulation of tau-protein kinase activity and biological process this GO :1902951 and negative regulation of dendritic spine maintenance and biological process this GO :1902952 and positive regulation of dendritic spine maintenance and biological process this GO :1902995 and positive regulation of phospholipid efflux and biological process this GO :1902998 and positive regulation of neurofibrillary tangle assembly and biological process this GO :1902999 and negative regulation of phospholipid efflux and biological process this GO :1903001 and negative regulation of lipid transport across blood brain barrier and biological process this GO :1903002 and positive regulation of lipid transport across blood brain barrier and biological process, apolipoprotein E |
| Identity: |
613 |
| Gene: |
APOE |
More about : APOE |
| Long gene name: |
apolipoprotein E |
| Synonyms gene: |
AD2 |
| Synonyms gene name: |
Alzheimer disease 2 (APOE*E4-associated, late onset) |
| Locus: |
19q13, 32 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
K00396 |
| Entrez gene record: |
348 |
| Pubmed identfication: |
10662539 |
| RefSeq identity: |
NM_000041 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000128901 |
| Locus Specific Databases: |
ALSOD, the Amyotrophic Lateral Sclerosis Online Genetic Database |